THC analyst estimates
Tenet Healthcare (THC) analyst ratings, the average price target and its range, and every firm's latest call.
THC analyst ratings and price targets
| Date | Firm | Call | Target |
|---|---|---|---|
| Oct 30, 2026 | Guggenheim | Tenet Healthcare (THC) PT Lowered to $306 at Guggenheim | $306.00 |
| Oct 16, 2026 | Guggenheim | Tenet Healthcare price target raised to $307 from $283 at Guggenheim | $307.00 |
| Sep 22, 2026 | BMO Capital | Tenet Healthcare initiated with a Market Perform at BMO Capital | $265.00 |
| Aug 14, 2026 | Raymond James | Tenet Healthcare price target raised to $285 from $275 at Raymond James | $285.00 |
| Aug 10, 2026 | Mizuho Securities | Tenet Healthcare price target raised to $290 from $250 at Mizuho | $290.00 |
| Aug 3, 2026 | Wells Fargo | Tenet Healthcare price target raised to $281 from $231 at Wells Fargo | $281.00 |
| Jul 28, 2026 | Robert W. Baird | Tenet Healthcare price target raised to $280 from $210 at Baird | $280.00 |
| Jul 28, 2026 | Truist Financial | Tenet Healthcare price target raised to $290 from $270 at Truist | $290.00 |
| Jul 28, 2026 | Goldman Sachs | Tenet Healthcare price target raised to $305 from $252 at Goldman Sachs | $305.00 |
| Jul 27, 2026 | RBC Capital | Tenet Healthcare price target raised to $283 from $236 at RBC Capital | $283.00 |
| Jul 27, 2026 | Raymond James | Tenet Healthcare (THC) PT Raised to $270 at Cantor Fitzgerald: Remains 'Top Provider Pick of 2026' | $270.00 |
| Jul 27, 2026 | Morgan Stanley | Tenet Healthcare price target raised to $274 from $254 at Morgan Stanley | $274.00 |
| Jul 27, 2026 | Piper Sandler | Tenet Healthcare (THC) PT Raised to $308 at UBS | $308.00 |
| Jul 27, 2026 | UBS | Tenet Healthcare price target raised to $308 from $288 at UBS | $308.00 |
| Jul 27, 2026 | Stephens | Tenet Healthcare price target raised to $285 from $250 at Stephens | $285.00 |
- 16 firms rate THC: 14 buy, 2 hold, 0 sell.
- The average price target is $289.23 from 13 analysts, from $265.00 to $308.00.
Updated 2026-11-02 23:10 UTC